Cleared Traditional

K240632 - Neuvotion NeuStim NN-01 (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240632 · Neuvotion, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
261d
Days
Class 2
Risk

K240632 is an FDA 510(k) clearance for the Neuvotion NeuStim NN-01. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Neuvotion, Inc. (Stamford, US). The FDA issued a Cleared decision on November 22, 2024 after a review of 261 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neuvotion, Inc. devices

Submission Details

510(k) Number K240632 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2024
Decision Date November 22, 2024
Days to Decision 261 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 148d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 60
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K240632.
Synchrony (20-3000)
K242704 · Synapse Biomedical, Inc. · Jun 2025
CIONIC NEURAL SLEEVE (NS-200)
K243828 · Cionic, Inc. · May 2025
MyndMove, MyndMove 2.0
K233006 · Myndtec, Inc. · Jun 2024
EvoWalk 1.0 System
K230997 · Evolution Devices, Inc. · Dec 2023
Cionic Neural Sleeve NS-100
K221823 · Cionic · Jul 2022
MyoCycle MC-2 (Home / Home + / Pro / Pro +)
K213925 · Myolyn, LLC · Apr 2022